Pancreatic cancer is a highly malignant disease. Delay in diagnosis and occurrence of early dissemination make chemotherapy to be an evitable treatment option for nearly all patients of pancreatic cancer regardless the disease stage at time of inital diagnosis. The advance of medical therapy for pancreatic cancer has been slow, only very limited agnets have been approved to be beneficial for survival prolongation. In this article, we shall review the recent development of chemotherapy in patients with metastatic, locally advanced and resectable pancreatic cancer.
Date:
2017-05-04
Relation:
Pancreatic Cancer: With Special Focus on Topical Issues and Surgical Techniques. 2017 May 4:387-419.
